Degree in Medical Biotechnology and Molecular Medicine, University of Bari, Italy in 2014. From 2014 to 2015: Research fellow at Diabetes Research Institute (DRI) at I.R.C.C.S. Ospedale San Raffaele, Milano – Italia. From 2016: Researcher at Laboratory of Experimental Pharmacology at IRCCS Istituto Tumori Giovanni Paolo II in Bari (Italy), and from 2021, a PhD student in Functional and Applied Genomics and Proteomics at the University of Bari in Bari, Italy.
Expertise in cellular and molecular biology, molecular pharmacology and animal handling. Previously, she was involved in autoimmunity and type 2 diabetes, in particular she focused on animal models of this disease. Now she focuses on preclinical pharmacology studies to assess the citotoxicity to cancer therapeutics in vitro (2D and 3D) and in vivo tumor models and in the identification of molecular mechanisms and predictive factors of response to combined treatments.
Degree in Medical Biotechnology and Molecular Medicine, University of Bari, Italy in 2014. From 2014 to 2015: Research fellow at Diabetes Research Institute (DRI) at I.R.C.C.S. Ospedale San Raffaele, Milano – Italia. From 2016: Researcher at Laboratory of Experimental Pharmacology at IRCCS Istituto Tumori Giovanni Paolo II in Bari (Italy), and from 2021, a PhD student in Functional and Applied Genomics and Proteomics at the University of Bari in Bari, Italy.
Expertise in cellular and molecular biology, molecular pharmacology and animal handling. Previously, she was involved in autoimmunity and type 2 diabetes, in particular she focused on animal models of this disease. Now she focuses on preclinical pharmacology studies to assess the citotoxicity to cancer therapeutics in vitro (2D and 3D) and in vivo tumor models and in the identification of molecular mechanisms and predictive factors of response to combined treatments.